FIELD: medicine.
SUBSTANCE: invention refers to treating overactive bladder in children. Method involves introduction of preparations, increasing bladder volume, and introduction of desmopressine (minirine) for 3 months. Additionally deficient antidiuretic hormone level night osmotic concentration of urine. If the osmotic concentration 202±44.9 mosm/l desmopressine (minirine) is introduced, starting with minimum dose of 60 mcg within month with reception of not later than 19 hours. Further, dose is increased through one and two months if night diuresis is more than 40 % of daily one.
EFFECT: method provides higher clinical effectiveness of the disease in children, including due to selected conditions and minirine administration.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PATIENTS AGED 14-17 WITH ENURESIS | 2023 |
|
RU2820167C1 |
| METHOD OF QUALIMETRY OF PELVIC ORGAN DYSFUNCTIONS IN CHILDREN | 2011 |
|
RU2472447C1 |
| METHOD OF TREATING CHILDREN SUFFERING NEUROGENIC BLADDER DYSFUNCTION WITH DECREASED URINATE ACTIVITY BY BIOLOGICAL FEEDBACK | 2010 |
|
RU2452531C1 |
| METHOD OF TREATMENT OF CHILDREN AGED 5 TO 17 YEARS WITH NEUROGENIC DETRUSOR HYPERACTIVITY IN COMBINATION WITH MYELODYSPLASIA AND VASCULAR HYPOTENSION | 2022 |
|
RU2799477C1 |
| REINFORCING AGENT WITH VASOPRESSIN-LIKE ACTION | 2016 |
|
RU2722344C2 |
| METHODS AND DEVICES FOR DESMOPRESSIN PREPARATION DELIVERY | 2008 |
|
RU2472539C2 |
| METHOD OF TREATMENT OF CHILDREN WITH ENURESIS | 2018 |
|
RU2680123C1 |
| SAFE APPLICATION OF DESMOPRESSINUM | 2010 |
|
RU2569756C2 |
| METHOD FOR CORRECTING NEUROGENIC DYSFUNCTION OF THE LOWER URINARY TRACT OF CENTRAL ORIGIN | 2021 |
|
RU2766762C1 |
| METHOD OF TREATING HYPERACTIVE BLADDER IN CHILDREN | 2013 |
|
RU2533019C1 |
